socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Monday, September 25, 2006

    NovaCardia Raises $48M in Series B
    San Diego-based NovaCardia, a company developing pharaceuticals for the treatment of cardiovascular disease based on small molecule drugs, said this morning it has raised $48M in a Series B funding. The funding was led by Skyline Ventures, and also included new investor InterWest Partners. Prior investors Domain Associates, Forward Ventures, Montreux Equity Partners, and Versant Ventures also participated in the round.
    posted on Monday, September 25, 2006 (Link to more information)

    Related companies:
    NovaCardia

    Related stories:
    > NovaCardia Appoints CFO
    > NovaCardia Acquired By Merck
    > NovaCardia Files For IPO
    > Merck Completes NovaCardia Buy
    > Sequel Pharmaceuticals Spins Out, Raises $20M

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Friday, September 5, 2008
    Thursday, September 4, 2008
    Wednesday, September 3, 2008
    Tuesday, September 2, 2008
    Friday, August 29, 2008